Frida Abel
-
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With
Cancer.
Elisabeth Wadensten, Sandra Wessman, Frida Abel, Teresita Diaz De Ståhl, Bianca Tesi, Christina Orsmark Pietras, Linda Arvidsson, Fulya Taylan, Susanne Fransson, Hartmut Vogt, Anna Poluha, Sailendra Pradhananga, Maria Hellberg, Kristina Lagerstedt-Robinson, Praveen Raj Somarajan, Sofie Samuelsson, Sara Orrsjö, Khurram Maqbool, Karin Henning, Tobias Strid, Torben Ek, Henrik Fagman, Thomas Olsson Bontell, Tommy Martinsson, Florian Puls, Per Kogner, Valtteri Wirta, Cornelis Jan Pronk, Joakim Wille, Richard Rosenquist, Monica Nistér, Fredrik Mertens, Magnus Sabel, Ulrika Norén-Nyström, Pernilla Grillner, Ann Nordgren, Gustaf Ljungman, Johanna Sandgren, David Gisselsson
JCO precision oncology - 2023 -
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic
paraganglioma
S. Karakaya, Lisa Gunnesson, Erik Elias, P. Martos-Salvo, M. Robledo, Ola Nilsson, Bo Wängberg, Frida Abel, S. Pahlman, Andreas Muth, S. Mohlin
Scientific Reports - 2023 -
Novel TPR::ROS1 Fusion Gene Activates MAPK, PI3K and JAK/STAT Signaling in an Infant-type Pediatric
Glioma.
Lily Deland, Simon Keane, Thomas Olsson Bontell, Henrik Fagman, Helene Sjögren, Anders E Lind, Helena Caren, Magnus Tisell, Jonas A Nilsson, Katarina Ejeskär, Magnus Sabel, Frida Abel
Cancer genomics & proteomics - 2022 -
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor
larotrectinib.
Lily Deland, Simon Keane, Thomas Olsson Bontell, Helene Sjögren, Henrik Fagman, Ingrid Øra, Esther De La Cuesta, Magnus Tisell, Jonas A Nilsson, Katarina Ejeskär, Magnus Sabel, Frida Abel
Cancer biology & therapy - 2021 -
MYO5B mutations in pheochromocytoma/paraganglioma promote cancer
progression
Tajana Tesan Tomic, Josefin Olausson, Anna Rehammar, Lily Deland, Andreas Muth, K. Ejeskar, Staffan Nilsson, Erik Kristiansson, Olof Nilsson Wassén, Frida Abel
Plos Genetics - 2020 -
A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic
astrocytoma
Tajana Tesan, Josefin Olausson, Annica Wilzén, Magnus Sabel, Katarina Truvé, H. Sjogren, S. Dosa, Magnus Tisell, Birgitta Lannering, F. Enlund, Tommy Martinsson, Pierre Åman, Frida Abel
PLoS ONE - 2017 -
Malignant pheochromocytomas/paragangliomas harbor mutations in transport and cell adhesion
genes.
Annica Wilzén, Anna Rehammar, Andreas Muth, Ola Nilsson, Tajana Tesan Tomic, Bo Wängberg, Erik Kristiansson, Frida Abel
International journal of cancer - 2016 -
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic
tumours.
Annica Wilzén, Cecilia Krona, Baldur Sveinbjörnsson, Erik Kristiansson, Daniel Dalevi, Ingrid Ora, Katleen De Preter, Raymond L Stallings, John Maris, Rogier Versteeg, Staffan Nilsson, Per Kogner, Frida Abel
Molecular cancer - 2013 -
Stage-dependent expression of PI3K/Akt‑pathway genes in
neuroblastoma.
Susanne Fransson, Frida Abel, Per Kogner, Tommy Martinsson, Katarina Ejeskär
International journal of oncology - 2013 -
Expression of TWEAK/Fn14 in neuroblastoma: Implications in
tumorigenesis
I. Pettersen, N. Baryawno, Frida Abel, W. H. Bakkelund, S. N. Zykova, J. O. Winberg, U. Moens, A. Rasmuson, P. Kogner, J. I. Johnsen, B. Sveinbjornsson
International Journal of Oncology - 2013 -
Prevalence of Germline Mutations in Patients with Pheochromocytoma or Abdominal Paraganglioma and Sporadic Presentation: A Population-Based Study in Western
Sweden.
Andreas Muth, Frida Abel, Svante Jansson, Ola Nilsson, Håkan Ahlman, Bo Wängberg
World journal of surgery - 2012 -
A 6-gene signature identifies four molecular subgroups of
neuroblastoma
Frida Abel, Daniel Dalevi, Maria Nethander, Rebecka Jörnsten, Katleen De Preter, Joëlle Vermuelen, Raymond Stallings, Per Kogner, John Maris, Staffan Nilsson
Cancer Cell International - 2011 -
Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor
genes.
Kaisa Thorell, Annika Bergman, Helena Carén, Staffan Nilsson, Per Kogner, Tommy Martinsson, Frida Abel
BMC medical genomics - 2009 -
The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene
PHOX2A.
Annica Wilzén, Staffan Nilsson, Rose-Marie Sjöberg, Per Kogner, Tommy Martinsson, Frida Abel
International journal of oncology - 2009 -
No germline mutations in supposed tumour suppressor genes SAFB1 and SAFB2 in familial breast cancer with linkage to
19p
Annika Bergman, Frida Abel, Afrouz Behboudi, Maria Yhr, Jan Mattsson, J. H. Svensson, Per Karlsson, Margareta Nordling
BMC Med Genet - 2008 -
Gene expression variation to predict 10-year survival in lymph-node-negative breast
cancer.
Elin Karlsson, Ulla Delle, Anna Danielsson, Björn Olsson, Frida Abel, Per Karlsson, Khalil Helou
BMC cancer - 2008 -
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma
tumours.
Helena Carén, Frida Abel, Per Kogner, Tommy Martinsson
The Biochemical journal - 2008 -
High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma
tumours
Helena Carén, Frida Abel, Per Kogner, Tommy Martinsson
Biochemical Journal - 2008 -
Significant Decrease in mRNA Expression of Five Genes Mapped at 1p36.2, comparing Favorable and Unfavorable
Neuroblastomas.
Susanne Fransson, Cecilia Krona, Rose-Marie Sjöberg, Frida Abel, Tommy Martinsson, Katarina Ejeskär
Advances in Neuroblastoma Research 2006, Los Angeles, USA, 2006 - 2006 -
Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable
biology.
Frida Abel, Rose-Marie Sjöberg, Staffan Nilsson, Per Kogner, Tommy Martinsson
European journal of cancer (Oxford, England : 1990) - 2005 -
A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma
tumours.
Cecilia Krona, Katarina Ejeskär, Helena Carén, Frida Abel, Rose-Marie Sjöberg, Tommy Martinsson
British journal of cancer - 2004 -
Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma
tumors.
Frida Abel, Rose-Marie Sjöberg, Cecilia Krona, Staffan Nilsson, Tommy Martinsson
International journal of oncology - 2004 -
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and
neuroblastoma.
D Astuti, M Morris, Cecilia Krona, Frida Abel, D Gentle, Tommy Martinsson, P Kogner, H P H Neumann, R Voutilainen, C Eng, P Rustin, Farida Latif, E R Maher
British journal of cancer - 2004 -
Genetic studies of neuroblastoma with emphasis on the apoptotic
pathway
Frida Abel
2004 -
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in
UBE4B/UFD2.
Cecilia Krona, Katarina Ejeskär, Frida Abel, Per Kogner, Jill Bjelke, Elin Björk, Rose-Marie Sjöberg, Tommy Martinsson
Oncogene - 2003 -
Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma
tumours.
Frida Abel, Rose-Marie Sjöberg, Katarina Ejeskär, Cecilia Krona, Tommy Martinsson
British journal of cancer - 2002 -
Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell
tumours.
Katarina Ejeskär, Rose-Marie Sjöberg, Frida Abel, Per Kogner, P F Ambros, Tommy Martinsson
Medical and pediatric oncology - 2001 -
Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3-->p36.2, but absence of mutations in primary
tumors.
Katarina Ejeskär, Frida Abel, Rose-Marie Sjöberg, J Bäckström, P Kogner, Tommy Martinsson
Cytogenetics and cell genetics - 2000 -
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at
17q24.
Frida Abel, Katarina Ejeskär, Per Kogner, Tommy Martinsson
British journal of cancer - 1999